poisar

Stocks · News reference

Nasdaq Falls Over 100 Points As Oil Prices Surge: Investor Sentiment Edges Lower, Greed Index Remains In ‘Fear’ Zone

BenzingaJul 23, 2026, 7:30 AMAvi Kapoor

CNN Fear & Greed index showed slight decline in market sentiment as crude oil prices rose. GEV & PEGA stocks fell, while T stock gained.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 23, 2026, 7:30 AM
Checked
Jul 23, 2026, 7:31 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolAug 23, 2026, 4:11 PMJames Brumley

    Gas Turbine Prices Are on Track to Nearly Triple. These Stocks Are Cashing In

    AI data centers are driving massive demand for natural gas power turbines to generate onsite electricity, with prices expected to nearly triple by end of 2025. Supply cannot keep up with demand, benefiting major turbine manufacturers. GE Vernova, Siemens Energy, and Mitsubishi Heavy Industries are the primary beneficiaries, with Caterpillar and Woodward also gaining from this trend.

    Read original at the-motley-fool
  2. Zacks Investment ResearchAug 27, 2026, 3:35 PMNa

    HON vs. EMR: Which Automation Stock Has Better Growth Potential?

    Honeywell Technologies and Emerson Electric are compared as industrial automation leaders. HON faces near-term headwinds from weak Process Automation demand, rising costs, and elevated debt ($31.5B), though Building and Industrial Automation segments show strength with 9% and 4% organic revenue growth respectively. EMR demonstrates broader momentum with 6% underlying sales growth, strength across power, LNG, aerospace, defense, and semiconductor markets, and strategic acquisitions enhancing its AI and software capabilities. Despite HON's Strong Buy rating, EMR appears the better investment choice given stronger recent stock performance, improving earnings outlook, and healthier end-market demand.

    Read original at zacks-investment-research